Cytori Therapeutics Inc (NASDAQ:CYTX) was Wall Street’s bull of the day today with shares that flew 74%. The cause of all the enthusiastic …
In a research note released yesterday, Roth Capital analyst Joseph Pantginis maintained coverage with a Buy rating on shares of Cytori Therapeutics (CYTX), and a price target of $10, following yesterday’s …
